Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| CGM & insulin pump management · Florida | CGM & insulin pump management · Texas | |
|---|---|---|
| Surgeons, 2024 | 404 | 452 |
| Medicare fee-for-service cases | 65,371 | 65,364 |
| Growth since 2019 (Medicare FFS) | +15%/yr | +17%/yr |
| Forecast cases (Medicare FFS) | 130,100 in 2030 | 129,200 in 2030 |
| Forecast growth | +12%/yr to 2030 | +12%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 28.7 | 29.8 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 96% (−4 pts since 2019) | 92% (−4 pts since 2019) |
| Cases per surgeon | 162 | 145 |
| Top 10 surgeons' share | 13% | 11% |
| Surgeons growing | 161 | 196 |
| New since the base year | 159 | 165 |
| Likely to stop billing it | 21 by 2026 | 14 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $2,711 | $3,777 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.